PCBL Chemical Ltd Q1 FY27 Results

PCBL Chemical Ltd reported a robust start to FY27, with revenue climbing 17% year-on-year to ₹2,474 crore and Profit After Tax (PAT) surging 65% to ₹155 crore. EBITDA saw a healthy 23% increase, reaching ₹400 crore.

Reader Takeaway: Strong earnings growth and new capacity boost; Q2 margin reversal and logistics costs are key concerns.

What just happened

For the first quarter of FY27, PCBL Chemical announced a 17% year-on-year increase in revenue, reaching ₹2,474 crore. The company also saw its EBITDA grow by 23% to ₹400 crore and its PAT surge by 65% to ₹155 crore. During the quarter, a new 20,000 MTPA specialty black line was commissioned, bringing the total operational capacity to 900,000 MTPA. Carbon black sales volume stood at 153,513 metric tons, with specialty carbon black sales at 19,748 tons.

Why this matters

The strong financial performance, driven by both volume growth and potentially favorable inventory accounting, indicates a positive start to the fiscal year. The commissioning of new specialty capacity signals a strategic move towards higher-value products, which could enhance future profitability. However, the anticipated reversal of inventory gains and rising logistics costs present challenges.

The backstory

PCBL Chemical, previously known as Phillips Carbon Black Limited, is a major player in the carbon black industry, a crucial component in tire manufacturing and other industrial applications. The company has been focusing on expanding its specialty chemicals portfolio and improving operational efficiencies. Aquapharm Chemicals, a subsidiary, is involved in specialty chemicals.

What changes now

The commissioning of the new specialty black line adds to the company's capacity and product diversification. The appointment of a new CEO for Aquapharm Chemicals, Rohit Narang, signals a renewed focus on strategic growth and mergers and acquisitions for that segment. Investors will be monitoring how these initiatives translate into future performance.

Risks to watch

Investors are cautioned about potential headwinds in the second quarter. Management expects a reversal of inventory gains that benefited Q1, potentially impacting margins. Additionally, volatile logistics costs due to geopolitical issues in the Middle East and erratic demand for Aquapharm's products due to oil and gas price volatility are significant concerns.

Peer comparison

Information on specific peers for Q1 FY27 performance was not provided in the filing. However, the carbon black industry is competitive, with companies like Birla Carbon (Aditya Birla Group) and Cabot Corporation being major global players.

Context metrics (time-bound)

• Q1 FY27 Revenue: ₹2,474 crore (up 17% YoY)
• Q1 FY27 EBITDA: ₹400 crore (up 23% YoY)
• Q1 FY27 PAT: ₹155 crore (up 65% YoY)
• New Capacity: 20,000 MTPA Specialty Black Line commissioned
• Total Capacity: 900,000 MTPA
• FY27 Capex Outlook: ₹300 crore (+/- ₹50 crore)

What to track next

Investors should closely watch Q2 volume trends, as customer procurement approaches may soften. Monitoring the company's ability to manage and pass on logistics costs will be crucial. The performance of Aquapharm, especially its green chelates business and M&A activities, will also be key.